Cystic fibrosis is one of the most common autosomal recessive genetic disorders in caucasians of Northern European descent, affecting approximately 30 000 children and adults living in the United States, today. Complications of this chronic disease result in deterioration of lung function and development of pancreatic abnormalities requiring pharmacological therapy and may include patients seeking complementary and alternative option for treatment. Health care professionals should be knowledgeable of these therapies to effectively provide education and drug therapy management. This article offers an overview of the most common complementary therapies in cystic fibrosis such as vitamin A, vitamin C, vitamin E, zinc, omega 3 fatty acids, docosahexaenoic acid (DHA), garlic, ginseng, and curcumin.
TanaseAZanniR. The use of complementary and alternative medicine among pediatric cystic fibrosis patients. J Altern Complement Med. 2008;14(10):1271–1273.
4.
SembaRDMuhilalWGriffinDEAbnormal T-cell subsets proportions in vitamin A deficient children. Lancet. 1993;341(8836):5–8.
5.
RossAC. Vitamin A status: relationship to immunity and antibody response. Proc Soc Exp Biol Med. 1992;200(3):303–320.
6.
RennerSRathRRustS, at al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax. 2001;56(1):48–52.
7.
WoodLGFitzgeraldDALeeAKImproved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr. 2003;77(1):150–159.
8.
SagelSDSontagMKAnthonyNMEffects of an antioxidant rich multivitamin supplement in cystic fibrosis. J Cyst Fibros. 2011;10(1):31–36.
9.
AbdulhamidIBeckFWMillardSEffect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr Pulmonol. 2008;43(3):281–287.
10.
PittsJFlackJGoodfellowJ. Improving nutrition in the cystic fibrosis patient. J Pediatr Health Care. 2008;22(2):137–140.
11.
DuriePR. The pathophysiology of the pancreatic defect in cystic fibrosis. Acta Paediatr Scand Suppl. 1989;363:41–44.
12.
MatelJLMillaCE. Nutrition in cystic fibrosis. Semin Respir Crit Care Med. 2009;30(5):579–586.
13.
KeremEReismanJCoreyMPrediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326(18):1187–1191.
14.
PowersSWPattonSRByarsKCCaloric intake and eating behaviors in infants and toddlers with cystic fibrosis. Pediatrics. 2002;109(5):E5–E75.
15.
TomezskoJLStallingsVAScanlinTF. Dietary intake of healthy children with cystic fibrosis compared with normal control children. Pediatrics. 1992;90(4):547–553.
16.
StarkLJJelalianEMulvihillMMEating in preschool children with cystic fibrosis and healthy peers: behavioral analysis. Pediatrics. 1995;95(2):210–215.
17.
StarkLJMulvihillMMJelalianEDescriptive analysis of eating behavior in school-age children with cystic fibrosis and healthy control children. Pediatrics. 1997;99(5):665–671.
18.
StarkLJJelalianEPowersSWParent and child mealtime behaviors in families of children with cystic fibrosis. J Pediatr. 2000;136(2):195–200.
19.
Aldamiz-EchevairiaLPrietoJAAndradeFPersistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy. Pediatr Res. 2009;66(5):585–589.
20.
Lloyd-StillJDPowersCAHoffmanDRBioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study. Nutrition. 2006;22(1):36–46.
21.
Van BiervlietSDevosMDelhayeTOral DHA supplementation in ▵F508 homozygous cystic fibrosis patients. Prostaglandin Leukot Essent Fatty Acids. 2008;78(2):109–115.
22.
OlveiraGOlveiraCAcostaEFatty acid supplementation improves respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis. Arch Bronconeumol. 2010;46(2):70–77.
23.
OliverCEverardMN’DiayeT.Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev. 2010;10:CD002201.
24.
SmythARCifelliPMOrtoriCAGarlic as an inhibitor of pseudomonas aeruginosa quorum sensing in cystic fibrosis-a pilot randomized controlled trial. Pediatr Pulmonol. 2010;45(4):356–362.
25.
AlipourMOmriASuntresZ. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, eradicates biofilms of pseudomonas aeruginosa. Can J Physiol Pharmacol. 2011;89(6):419–427.
26.
SongZWuHHoibyNGerimax ginseng regulates both hymoral and cellular immunity during chronic pseudomonas aeruginosa lung infection. J Altern Complement Med. 2002;8(4):459–466.
